• Featured Product
  • KD/KO Validated

CYP2W1 Polyclonal antibody

CYP2W1 Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

Cat no : 12904-1-AP

Synonyms

EC:1.14.14.-, Cytochrome P450 2W1, CYPIIW1



Tested Applications

Positive WB detected inHEK-293 cells, HepG2 cells, NIH/3T3 cells
Positive IHC detected inhuman stomach cancer tissue, human colon cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 1 publications below

Product Information

12904-1-AP targets CYP2W1 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen CYP2W1 fusion protein Ag3803
Full Name cytochrome P450, family 2, subfamily W, polypeptide 1
Calculated Molecular Weight 54 kDa
Observed Molecular Weight 45-54 kDa
GenBank Accession NumberBC025761
Gene Symbol CYP2W1
Gene ID (NCBI) 54905
RRIDAB_10644150
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Cytochrome P450s have been proposed to be of importance both in carcinogenesis, by activating precarcinogens, and as determinants of cancer chemotherapy, where they participate in activation or inactivation of anti-cancer drugs. CYP2W1 is exclusively expressed in transformed tissue in the adult human, mainly in colon tumors. It is a potential drug target in cancer therapy. CYP2W1 has a molecular weight of 52-54 kDa, and 30/45 kDa of potential isoforms.

Protocols

Product Specific Protocols
WB protocol for CYP2W1 antibody 12904-1-APDownload protocol
IHC protocol for CYP2W1 antibody 12904-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Pharmacol Rep

Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.

Authors - Hanna Szaefer